Bora Pharmaceuticals Co. Ltd. and Corealis Pharma Inc. have entered into a strategic alliance to provide end-to-end services ...

Ability Biotherapeutics, a biotechnology company, has appointed Angèle Maki, PhD, as Chief Business Officer (CBO).

ProBioGen and Spica Therapeutics, a biotechnology company advancing pathogenic macrophage subset-targeted immunotherapies, ...

Marchesini Group and AST have entered a strategic partnership that combines their expertise, technologies, and global reach.

Nigel Langley of gCHEM discusses the advantages of its high-purity Dimethyl sulfoxide in pharmaceutical applications.

The renewed agreement supports Merck’s efforts to integrate AI more deeply into its scientific workflows. With ongoing access ...

Cellular Origins, a company that enables the manufacturing of cell therapies at scale, has completed a $40 million ...

Pfizer has entered into an exclusive global collaboration and license agreement with YaoPharma for the development, ...

Mirum Pharmaceuticals Inc. has agreed to acquire Bluejay Therapeutics, a privately held biotechnology company focused on ...

Natera Inc., a cell-free DNA and precision medicine company, has acquired Foresight Diagnostics, a leader in ultrasensitive ...

Quotient Sciences and Intrepid Labs have announced a multi-year strategic partnership to advance the use of artificial ...

Jubilant Therapeutics Inc., a clinical-stage biopharmaceutical company, has appointed Daniel J. O'Connor as President & Chief ...